Remove Eating disorders Remove Genetics and mental health Remove Presentation
article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

article thumbnail

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

Together, they will aim to bring innovative mental health treatments to patients in need. Participants include 30 young adults diagnosed with BPD and 20 young adults with no mental health diagnosis, who are observed using EEG and behavioral assessments to gather objective data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is Ondansetron Safe for Women With Mental Health Conditions?

Lightwork

Navigating medication safety during pregnancy can feel overwhelming, especially for women managing mental health conditions. For women with mental health conditions, the decision to use ondansetron requires careful consideration. The rising use of ondansetron for pregnancy-related nausea presents a complex scenario.

article thumbnail

Role of Pediatricians in Diagnosing ADHD

Psychiatric Times

Role of Pediatricians in Diagnosing ADHD Pediatricians serve as frontline healthcare providers for ADHD diagnosis and treatment, positioned at the initial point of contact alongside schools where children first present with concerning symptoms. Subscribe Now!

article thumbnail

Prodromal Symptoms of Schizophrenia: Understanding and Addressing Challenges

Psychiatric Times

Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. The DSM-5 task force concluded that there was not enough evidence to justify incorporating APS as an official mental disorder diagnosis in Section II.

article thumbnail

MAHA Report: 3 Takeaways for the ADHD Community

ADDitude

The MAHA Report , spearheaded by Health and Human Service (HHS) Secretary Robert F. It disregards the genetic underpinnings of ADHD to suggest it is caused by environmental factors and foods, twists data to stoke fear over rising diagnosis rates, and excludes a wealth of studies that link stimulant medication use to improved health outcomes.

article thumbnail

New Research From Clinical Psychological Science

Association for Psychological Science (APS)

A Brief Group Social-Belonging Intervention to Improve Mental-Health and Academic Outcomes in BIPOC and First-Generation-to-College Students Erin S. Understanding Ethnoracial Disparities and Advancing Mental Health Equity Through Clinical Psychological Science: Introduction to Special Issue P. Affective (i.e.,